Further, the actin-binding protein Tagln2 was suggested as a diagnostic biomarker of HCC as it is overexpressed in 69% of patients and was described to be a target of TGF-β/Smad4 in colon cancer cells [40,41]. This evidence concerns the gene SMAD4 and colonic neoplasm.